TROGENIX LTD
Significant control: 4bio Ventures Iii Gp LLP (25–50%), Iq Capital Partners LLP (significant control)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
What does Trogenix Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
TROGENIX LTD is an active private limited company (company number 14930146) incorporated on 12 June 2023, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Accounts are on file at Companies House (total exemption full) but not yet parsed into this record.
There are 603 companies in research and experimental development on biotechnology in London with filed accounts; the median reports net assets of £440 and is 6 years old.
Ownership and control
- 4bio Ventures Iii Gp Llp
- owns 25–50% of shares
- holds 25–50% of voting rights
- Iq Capital Partners Llp
- has significant influence or control
- Prof Steven Michael Pollard
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 12 June 20233 yrs ago
- First accounts due
- 12 March 2025590 days overdue
- Confirmation statement due
- 26 June 2027in 246 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
Financials
Accounts exist on the register but their figures are not in this dataset yet.
Filing and accounts signals
- Incorporated two to five years agoIncorporated 12 June 2023
- Accounts past their due dateDue 12 March 2025
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 246 days
- First accounts due590 days overdue
- Incorporated
Similar companies in London
- AUROBAC THERAPEUTICS UK LIMITEDLondon · inc. Jun 2023
- FULL CIRCLE BIOTECHNOLOGY LTDLondon · inc. Jun 2023
- EXERT THERAPEUTICS LIMITEDLondon · inc. Jun 2023
- MELIAN DIALOGUE LTDLondon · inc. Jun 2023
- OMNIPOTENT BIO LTDLondon · inc. Jun 2023
- EADSVIEW LIMITEDLondon · inc. Jun 2023
All companies incorporated on 12 June 2023 · in Jun 2023.
Reminders for TROGENIX LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.